ALL	acute lymphoblastic leukemia
AML	acute myeloid leukemia
Antp	Drosophila Antennapedia protein
BCL	B cell lymphoma
BRCA	Breast Cancer-associated Protein
CAF	chromatin assambly complex
CAK	CDK-activating kinase
CDK	cyclin-dependent kinase
CDKI	cyclin-dependent kinase inhibitor
Cip/Kip	CDK interacting protein/Kinase inhibitory protein
CLL	chronic lymphocytic leukemia
CPP	cell penetrating peptide
CR	complete response
CRC	colorectal cancer
DLT	dose-limiting toxicity
DSB	double-strand breaks
EGFR	epidermal growth factor receptor
EMT	epithelial-mesenchymal transition
HCC	hepatocellular carcinoma
HNSCC	head and neck squamous cell carcinoma
HPV	human papillomavirus
IC50	half maximal tolerated dose
ICB	immune checkpoint blockade
IFN	Interferon
LCSC	lung cancer squamous cell
M phase	mitosis phase
MCL	mantle cell lymphoma
MM	multiple myeloma
MTD	maximum tolerated dose
NHL	non-Hodgkin’s lymphoma
NPC	nasopharyngeal carcinoma
NSCLC	non-small cell lung cancer
OS	overall survival
OSCC	oral squamous cell carcinoma
PDK1	3-phosphoinositide-dependent protein kinase 1
PDX	patient derived xenograft
PFS	Progression-Free Survival
PPI	protein-protein interactions
PR	partial response
pRb	phosphorylated retinoblastoma protein
PROTAC	proteolysis targeting chimera
P-TEFb	positive transcription elongation factor b
Rb	retinoblastoma protein
RP2D	recommended phase II dose
R-point	restriction point
RNA Pol II	RNA Polymerase II
S phase	synthesis phase
SCLC	Small-cell lung cancer
SLL	small lymphocytic lymphoma
Ser/Thr	serine/threonine
SR	stable disease
T-ALL	T cell acute lymphoblastic leukemia
TGF	Transforming Growth Factor
TK1	Thymidine Kinase 1
TRAIL	TNF-related apoptosis-inducing ligand